FGF2 and breast carcinoma: Furthermore, it has been demonstrated that VEGF is essential for the initial but not continued growth of human breast carcinoma cells in vivo, and that other angiogenic factors, such as b-FGF, can substitute for VEGF during disease progression (Yoshiji et al, 1997).